ID: ALA341629

Max Phase: Preclinical

Molecular Formula: C19H16O5

Molecular Weight: 324.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CCOc1ccc2c(=O)c3cccc(CC(=O)O)c3oc2c1C

Standard InChI:  InChI=1S/C19H16O5/c1-3-9-23-15-8-7-14-17(22)13-6-4-5-12(10-16(20)21)19(13)24-18(14)11(15)2/h3-8H,1,9-10H2,2H3,(H,20,21)

Standard InChI Key:  SHMYKBWLSQUOCY-UHFFFAOYSA-N

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 324.33Molecular Weight (Monoisotopic): 324.0998AlogP: 3.45#Rotatable Bonds: 5
Polar Surface Area: 76.74Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.23CX Basic pKa: CX LogP: 3.68CX LogD: 0.24
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.57Np Likeness Score: 0.19

References

1. Gobbi S, Rampa A, Bisi A, Belluti F, Valenti P, Caputo A, Zampiron A, Carrara M..  (2002)  Synthesis and antitumor activity of new derivatives of xanthen-9-one-4-acetic acid.,  45  (22): [PMID:12383019] [10.1021/jm020929p]

Source